InDevR Raises $9 Million in Series B Financing and Partners with bioMérieux Boulder, CO, 17 January 2023 – InDevR, Inc., a provider of best-in-class analytical technologies for vaccines and biotherapeutics, [...]
Vaccines Research & Development - November 7-9, 2022 InDevR will be presenting an Exhibitor Talk on November 7 at 12:50 - 1:00 pm ET. Speaker: April Blodgett To see [...]